• 17999 Citations
  • 64 h-Index
1974 …2020
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Pierfranco Conte is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 75 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Epirubicin Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Cisplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1974 2020

  • 17999 Citations
  • 64 h-Index
  • 475 Article
  • 4 Review article
  • 2 Chapter
  • 2 Comment/debate

Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy

Dal Maso, A., Lorenzi, M., Roca, E., Pilotto, S., Macerelli, M., Polo, V., Cecere, F. L., Del Conte, A., Nardo, G., Buoro, V., Scattolin, D., Monteverdi, S., Urso, L., Zulato, E., Frega, S., Bonanno, L., Indraccolo, S., Calabrese, F., Conte, P. F. & Pasello, G., Jan 2020, In : Clinical Lung Cancer. 21, 1, p. 1-14.e3

Research output: Contribution to journalArticle

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer

SOLAR-1 Study Group & Aieta, M., May 16 2019, In : The New England journal of medicine. 380, 20, p. 1929-1940 12 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Open Access
Tumor-Infiltrating Lymphocytes
Disease-Free Survival
Breast Neoplasms
Confidence Intervals
Proportional Hazards Models

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events

Grisanti, S., Bianchi, S., Locati, L. D., Triggiani, L., Vecchio, S., Bonetta, A., Bergamini, C., Conte, P., Airoldi, M., Merlano, M., Carlini, P., Ibrahim, T., Rossetto, C., Alfieri, S., Pronzato, P., Tonoli, S., Maroldi, R., Nicolai, P., Resteghini, C., Magrini, S. M. & 1 others, Berruti, A., Mar 1 2019, In : PLoS One. 14, 3, e0213934.

Research output: Contribution to journalArticle

Open Access
metastasis
neck
Bone
Neck
Nasopharyngeal Neoplasms
11 Citations (Scopus)

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: Results of the PerELISA neoadjuvant study

Guarneri, V., Dieci, M. V., Bisagni, G., Frassoldati, A., Bianchi, G. V., De Salvo, G. L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C. A., Moretti, G., Griguolo, G., Vicini, R., Prat, A. & Conte, P. F., Jun 1 2019, In : Annals of Oncology. 30, 6, p. 921-926 6 p., mdz055.

Research output: Contribution to journalArticle

Open Access
letrozole
Hormones
Breast Neoplasms
Therapeutics
Drug Therapy